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Conclusion
LDCs are immature and tolerogenic in the steady state. 
During chronic liver injuries a pro-inflammatory LDC 
population prevails, while in acute liver damage LDCs 
appear to be protective, preventing structural damage.
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The phenotype and function of liver dendritic cells (LDCs) are poorly 
understood. This Snapshot summarizes our current knowledge 
on LDCs in the healthy and injured liver, and their role in fibrosis 
progression and reversal. It also draws attention to various pitfalls in 
the current experimental design and conclusions based on available 
data.
LDC populations
DCs are the major APCs and link innate and adaptive immunity. LDCs 
localize within the portal area of the healthy liver and sparsely in 
the parenchyma [1]. The population of LDCs is heterogeneous and 
three murine LDC subsets can be distinguished: CD103+, CD103−, 
and pDCs [1,2] (panel A, figure). LDC development is regulated by 
transcription factors, which mediate DC-development in lymphoid and 
other non-lymphoid organs [2,3]. The liver contains DC precursors 
from which LDCs can be expanded in situ via GM-CSF or FLT3L [1,2]. 
Our current understanding of LDCs is largely based on the evaluation 
of either MHCII+ myeloid or CD11c+ cell populations, only part of which 
may be true LDCs. Less is known about the role of LDCs in humans.
LDCs as mediators of tolerance
CD11c+ cells from the healthy liver display a low capability to 
endocytose antigens and to stimulate T cells, but produce increased 
IL-10 compared to their splenic counterpart [1]. This tolerogenic 
phenotype appears to help maintain allograft survival after liver 
transplantation [1]. Notably, the hepatic microenvironment promotes 
regulatory DC development, and likely educates circulating DCs as they 
translocate from the blood to the lymph via the hepatic sinusoids [1]. 
LDCs generated from LDC precursors demonstrate low expression of 
co-stimulatory molecules and are resistant to conventional maturation 
stimuli (LPS, TNFα) [1], consistent with their immature phenotype 
despite constant exposure to gut-derived bacterial products. Instead, 
LDCs mature after attachment to ECM (e.g., fibronectin, collagen-type 
I, laminin) [1] in vitro, yet the relevance in vivo is unknown. A valuable 
classification of LDCs exists according to their lipid content [4]. HL-
LDCs, displaying elevated triglycerides and phospholipids due to their 
acetyl-CoA carboxylase activity, can mount a strong CTL response, 
while LL-LDCs (low triglycerides, phospholipids) are less mature and 
can induce oral tolerance [4]. Liver pDCs, different from LL-LDCs, can 
also mediate oral tolerance, suggesting the involvement of multiple 
LDC subsets [1].
Pro-inflammatory LDCs in liver injury
In the models of MCD-diet-induced NASH and TAA-induced fibrosis, 
HL-LDCs were the dominating hepatic DC species, characterized 
by increased TNFα production, FA synthesis, and endoplasmic 
reticulum stress [4]. Surface marker analyses of HL-LDCs revealed 
the involvement of multiple LDC subsets [4]. Increased numbers of 
monocyte-derived CD11c+ cells were observed in biliary fibrosis 
(BDL), with higher capacity to acquire antigen and stimulate T cells 
[1,2]. CD11c+ cells were elevated up to 7-fold in fibrosis induced 
by TAA and recombinant leptin, producing excess IL-6, TNFα, and Journal of Hepatology 2013 v
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as dependent on IL-1 and TNFα production by F4/80+ macrophages 
d only marginally by LDCs. Repetitive depletion of F4/80+, but not 
D11c+ cells, ameliorated fibrosis progression, thus proinflammatory 
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 acetaminophen-induced acute liver injury, depletion of CD11c+
lls exacerbated liver pathology [7]. Here expansion of the 
D11b+CD11c+ population induced neutrophil apoptosis, inhibited NK
ll cytolytic activity and decreased hepatocyte necro-apoptosis [7].
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rolytic CD11b+F4/80+ cells were recently characterized as MMP9 
pressing Ly6Clo monocyte-derived macrophages [11]. Due to 
erlapping surface markers among monocytes, macrophages and 
Cs, it remains unclear to what extent LDCs contribute to fibrolysis 
sides the better defined role of macrophages.
ovel possibilities for studying LDCs
e CD11c-DTR model has been the most widely used animal 
odel in LDC biology. DT treatment of BM-chimeras (CD11c-DTR 
M transferred to irradiated wild type mice) results in the depletion 
 LDCs. However, this treatment also affects CD11c+ macrophages,
onocytes, NK cells, and pDCs [12]. A novel, yet understudied model 
 the zbtb46-DTR mouse [13], based on a transcription factor that is 
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LDCs are immature and tolerogenic in the steady state. During 
chronic liver injuries a pro-inflammatory LDC population prevails, 
while in acute liver damage LDCs appear to be protective, preventing 
structural damage (panel B, figure). In many studies, the employed 
surface markers did not permit a differentiation of LDCs from e.g., 
monocytes, macrophages or other myeloid cells, stressing the need 
to use better surface markers and transgenic tools for studying DC 
biology in the liver.
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